Hematological disorders, solid tumors
Conditions
Interventions
None listed
Sponsors
Center for Advanced Medicine and Clinical Research, Nagoya University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who underwent allogeneic hematopoietic cell transplantation in Japan between 1998 and 2013 and whose data were registered in the TRUMP database
Exclusion criteria
Exclusion criteria: Patients who refused the use of their data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The optimal size of registered donors and preserved cord blood units | — |
Countries
Japan
Contacts
Public ContactSatoshi Nishiwaki
Nagoya University Hospital Center for Advanced Medicine and Clinical Research
Outcome results
None listed